University of Fukui · Center for Cancer Care Promotion

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer2026 · Japanese Journal of Clinical Oncology. 56 , 3 , p. 274-281 8 p. 研究成果 : ジャーナルへの寄稿 › 学術原著論文 › 査読
• Optimizing chemotherapy regimens and dosing for older patients with metastatic pancreatic cancer: insights from the Tokushukai real-world data project2026 · BMC Cancer. 26 , 1 , 378. 研究成果 : ジャーナルへの寄稿 › 学術原著論文 › 査読
• Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes2026 · International Journal of Clinical Oncology. 31 , 1 , p. 203-213 11 p. 研究成果 : ジャーナルへの寄稿 › 学術原著論文 › 査読 Cervical Cancer 100% Immune Checkpoint Inhibitor 100% Uterine Cervix Cancer 100% Survival Time 27% Tumor 27%
• Comparative review of KEYNOTE-689 and NIVOPOSTOP trials and their impact on perioperative immunotherapy in locally advanced head and neck cancer2025 · Cancer Treatment Reviews. 140 , 103018. 研究成果 : ジャーナルへの寄稿 › 総説 › 査読

• カルテ情報・院内がん登録・ＤＰＣデータを用いた徳洲会がんリアルワールド解析

• Official profile